Orion Group Holdings (ORN) Company Overview

Orion S.A. (OEC) stock has disappointed, and execution remains a primary concern. But the potential for substantial rewards exists if Orion can finally deliver on its growth projections and improve operational execution. Management's mid-cycle estimate of $500 million in Adjusted EBITDA "capacity" suggests significant upside, especially if cyclical trends turn favorable.

HEALWELL expects to achieve at least $3.0 million in annual cost savings through a strategic cost optimization initiative. HEALWELL is focussed on aligning its operations ahead of the anticipated closing of its previously announced acquisition of New Zealand based Orion Health ("Orion") to optimize synergies and streamline operations between the two companies.

PHOENIX--(BUSINESS WIRE)--Orion Office REIT Inc. Announces Tax Treatment of 2024 Dividends.

OMAHA, Neb.--(BUSINESS WIRE)--Orion, the premier provider of transformative wealthtech solutions for financial advisors and the enterprises that serve them, today announced a new collaboration with Snowflake, the AI Data Cloud company. This initiative further enhances data access and flexibility for Orion clients, moving just-in-time reporting into the hands of the advisor. The Snowflake technology will be available to a beta group of clients in Q2 with general availability to be announced late.

ORN benefits from increased government and private sector spending amid increased cost and expense struggles. Know which factors are affecting the stock.

PHOENIX--(BUSINESS WIRE)--Orion Office REIT Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release and Webcast Dates.

This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated August 12, 2024, to its short form base shelf prospectus dated June 21, 2024 RENO, Nev. , Jan. 15, 2025 /PRNewswire/ - i-80 GOLD CORP.

HOUSTON--(BUSINESS WIRE)--Orion S.A. (NYSE: OEC), a global specialty chemicals company, today announced a preliminary unaudited financial update for its fiscal year ending December 31, 2024. Orion now expects 2024 adjusted EBITDA to be nominally below our guidance range of $305-$315 million, due primarily to foreign exchange translation impacts related to the strengthening dollar and one-time costs associated with a cost reduction plan. Weaker than anticipated Rubber segment volumes late in the.

The Company has obtained shareholder approval for its proposed acquisition of Orion Health and its previously announced $55 million bought-deal financing. The Company also announced that a Schedule A Bank has obtained internal risk approval for a senior secured credit facility in the amount of $50 million, subject to the Company finalizing a credit agreement with the Bank.